Renalytix
Entity

  • Renalytix



  • Up & running (A)
    Existing signals show a regular activity

  • Social networks

    3,927

  • Activities

    healthtech deeptech

  • Entity types

    Startup

  • Location

    1460 Broadway, New York, NY 10036, USA

    New York

    United States of America

  • Employees

    Scale: 51-200

    Estimated: 51

  • Engaged catalyst

    0
    0 0

  • Added in Motherbase

    2 years, 3 months ago
Description
  • Value proposition

    Our singular goal is to eradicate kidney disease.

    Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosisTM for kidney health. We’ve engineered a proprietary solution that successfully enables early-stage, progression risk assessment when it counts the most.

    Renalytix. Right here, until kidney disease isn’t.TM

  • Renalytix - Renalytix

    Our singular goal is to eradicate kidney disease. With our KidneyIntelX™ technology, we help clinical teams understand patient level of risk for progressive decline in kidney function in the earliest stages of diabetic kidney disease. Knowing patient risk early enables clinicians to focus resources and guideline-recommended treatment accordingly, which provides the best chance for improving

    • https://renalytix.com/
Catalyst interactions
Catalyst TypeTweets Articles
No interactions
Social network dynamics
Last news
Show all articles